Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $31.95 USD
Change Today -0.09 / -0.28%
Volume 341.5K
HAE On Other Exchanges
As of 8:04 PM 02/10/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

400 Wood Road

Braintree, MA 02184

United States

Phone: 781-848-7100


Haemonetics Corporation, a healthcare company, provides blood management solutions to customers. The company’s portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes for blood and plasma collectors, hospitals, and patients worldwide. Its products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does. Primarily, the company develops and markets a range of blood collection and processing systems used with plasma and blood donors that collect and process blood into its components using both manual and automated methods. It also develops and markets various systems to hospitals that automate the cleaning and reinfusion of a surgical patient's own blood, automate the tracking and distribution of blood in the hospital, and improve blood diagnostics. The company also sells information technology platforms to promote compliant operations for all of its customer groups. In addition, the company provides consulting services to improve operating efficiencies in blood management. By understanding its customers' needs, the company is creating blood management solutions for blood collectors and healthcare systems in approximately 100 countries worldwide. Product Lines The company serves three customer segments, such as manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals. The company operates under four global product categories: Plasma, Blood Center, Hospital, and Software Solutions. Plasma includes plasma collection devices and disposables. Blood Center includes blood collection and processing devices and disposables. Hospital includes surgical blood salvage and blood demand diagnostic devices and disposables. Software Solutions includes information technology platforms and consulting services provided to all three markets. Although the company addresses its customers' needs through multiple product lines, the company manages its business as five operating segments based primarily on geography, such as North America Plasma, North America Blood Center and Hospital, Europe, the Asia Pacific, and Japan. Plasma The Plasma Collection Market for Fractionation — The company manufactures and markets automated plasma collection devices and respective disposables, but does not make plasma-derived pharmaceuticals. Plasma Products: The company’s portfolio of products and services is designed to support multiple facets of plasma collector operations. With its PCS brand automated plasma collection technology, more plasma could be collected during any one donation event because the other blood components are returned to the donor through the sterile disposable sets used for the plasma donation procedure. The company offers ‘one stop shopping’ to its plasma collection customers, enabling them to source from the company the range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions. The company also offers a portfolio of integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain. The company’s products automate the donor interview and qualification process; streamline the workflow process in the plasma center; provide the controls necessary to evaluate donor suitability; determine the ability to release units collected; and manage unit distribution. Blood Center The company offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The company markets the MCS (Multicomponent Collection System) brand apheresis equipment, which is designed to collect specific blood components integrated from the donor. Utilizing the MCS automated platelet collection protocols, blood centers collect one or more therapeutic ‘doses’ of platelets during a single donation. The MCS two-unit protocol or double re


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $31.95 USD -0.09

HAE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fresenius SE & Co KGaA €54.43 EUR +1.31
Medtronic PLC $74.16 USD +1.08
Terumo Corp ¥3,820 JPY -60.00
View Industry Companies

Industry Analysis


Industry Average

Valuation HAE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HAEMONETICS CORP/MASS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at